A detailed history of Keystone Investors Pte LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Keystone Investors Pte LTD holds 793 shares of LLY stock, worth $598,715. This represents 0.06% of its overall portfolio holdings.

Number of Shares
793
Holding current value
$598,715
% of portfolio
0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $612,307 - $761,295
793 New
793 $702,000
Q4 2023

Feb 07, 2024

BUY
$525.19 - $619.13 $9.87 Million - $11.6 Million
18,799 Added 34.43%
73,399 $42.8 Million
Q3 2023

Nov 09, 2023

BUY
$434.7 - $599.3 $23.7 Million - $32.7 Million
54,600 New
54,600 $29.3 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Keystone Investors Pte LTD Portfolio

Follow Keystone Investors Pte LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keystone Investors Pte LTD, based on Form 13F filings with the SEC.

News

Stay updated on Keystone Investors Pte LTD with notifications on news.